Inmunoterapia en 1L del CPCNP: monoterapia y/o tratamiento combinado - page 10

1L NSCLC: CheckMate 026

Socinski M, et al. ESMO 2016

32-46%

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7,8,9 11,12,13,14,15,16,17,18,19,20,...42